N/A
N=10
Assessment of Limb Perfusion During Junctional Tourniquet
Bleeding
Bottom Line
View on ClinicalTrials.gov: NCT02092415 ↗Enrolled (actual)
10
Serious AEs
0.0%
Results posted
May 2015
Primary outcome: Primary: Muscle Perfusion — 0.32; 0.10 IU/s
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Application of a Junctional Tourniquet (Device)
- Age
- Adult · 19+ yrs
- Sex
- All
- Sponsor
- Oregon Health and Science University
- Primary completion
- Mar 2014
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Muscle Perfusion |
0.32; 0.10 | — |
Summary
The goal of this study is to use contrast enhanced ultrasound to determine the degree to which flow is reduced during application of a junctional tourniquet (JT). Contrast enhanced ultrasound is performed to quantify thigh and calf perfusion at baseline and during application of the JT
Eligibility Criteria
Inclusion Criteria
- Healthy subject
- Age 19-50
Exclusion Criteria
- Peripheral artery disease
- Known heart failure
- Right to left shunt
- Pregnancy
- Presence of femoral artery aneurysm
Data sourced from ClinicalTrials.gov (NCT02092415). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.